GENDER PECULIARITIES OF THE OSTEOPENIC SYNDROME IN THE DEPENDENCE ON THE RHEUMATOID INFLAMMATION ACTIVITY
https://doi.org/10.14412/1996-7012-2010-616
Abstract
Objective. The gender differences estimation of mineral bone density (MBD) dependence on the rheumatoid inflammation activity degree.
Subjects and methods. 132 patients with the significant RA diagnose are included into the research among them there are 80 males (the main
group), 28 females with retained menstrual cycle, 24 females in post-menopause. The control group (for the main) is 84 males without RA compared by the age. MBD was measured by the method of double-energetic absorptiometry with the help stationary radiological double-energetic bone densitometer Exceell XR-46 (Norland, USA).
Results. The patients with RA had the significant decreasing of T-criteria and MBD in comparison with indexes of the control group. The average meaning of densitometric indexes at the males with the 3rd activity degree were significantly lower than at the males with the 2nd activity degree. The most risk of osteoporosis (OP) development has been noted at the males and females in post-menopause at the 3rd activity degree.
RA at the males is reasonable to consider as a prognostic marker of unfavorable influence on MBD and high activity as a risk factor of OP development associated with the disease itself.
Subjects and methods. 132 patients with the significant RA diagnose are included into the research among them there are 80 males (the main
group), 28 females with retained menstrual cycle, 24 females in post-menopause. The control group (for the main) is 84 males without RA compared by the age. MBD was measured by the method of double-energetic absorptiometry with the help stationary radiological double-energetic bone densitometer Exceell XR-46 (Norland, USA).
Results. The patients with RA had the significant decreasing of T-criteria and MBD in comparison with indexes of the control group. The average meaning of densitometric indexes at the males with the 3rd activity degree were significantly lower than at the males with the 2nd activity degree. The most risk of osteoporosis (OP) development has been noted at the males and females in post-menopause at the 3rd activity degree.
RA at the males is reasonable to consider as a prognostic marker of unfavorable influence on MBD and high activity as a risk factor of OP development associated with the disease itself.
References
1. <div><p>Рожинская Л.Я. Системный остеопороз. М., 2000; 196 с.</p><p>Лазебник Л.Б., Маличенко С.Б. Остеопороз: Метод. рук-во. М., 1997; 62 с.</p><p>Rochira V., Balestrieri A., Madeo B. et al. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho) physiology. Eur J Endocrinol 2006; 154(2): 175-85.</p><p>Остеопороз. Диагностика, профилактика и лечение: клинические рекомендации. Под ред. Л. И. Беневоленской. М., 2005.</p><p>O'Neill T.W., Felsenberg D., Varlow J. et al. The prevalence of Vertebral Deformity in Europen Men and Women: The European Vertebral Osteoporosis Study. J Bone Miner Res 1996; 11(7): 1010-6.</p><p>Jackson S.A., Tenenhouse A., Robertson L. Vertebral Fracture Definition from Population - Based Data: Preliminary Results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 2000; 11: 680-7.</p><p>Amen S., Felson D.T. Osteoporosis in men. Rheum Dis Clin North Am 2001; 27: 19-47.</p><p>Forsen L., Sogaard A.J., Mever H.E. et al. Survival after hip fracture: short- and long- term mortality accordIng to age and gender. Osteoporos Int 1999; 10: 73-8.</p><p>Binkley N. Osteoporosis in men. Arq Bras Endocrinol Metabol 2006; 50(4): 764-74.</p><p>Bailine S.P., Davidson C.E., Jihnson F.J. et al. Pathogenesis of vertebral crush fracture in man. Age Aging 1992; 21: 139-41.</p><p>Насонов Е.Л., Скрипникова И.А., Беневоленская Л.И. и др. Патогенез остеопороза: анализ иммунологических механизмов. Клин. ревматол. 1996; 3.</p><p>Насонов Е.Л., Скрипникова И.А., Насонова В.А. и др. Проблема остеопороза в ревматологии. М.: Стин, 1997; 326 с.</p><p>Fisher J.E., Rodan G.A., Reszka A.A. In vivo effects of bisphoshonates on the osteoclast mevalonate pathway. Endocrinology 2000; 14: 4793-6.</p><p>Rogers M.J. New insights into the molecular mechanisms of action of bisphoshonates. Curr Pharm Des 2003; 9: 2643-58.</p><p>Марусенко И.М., Барышева О.Ю., Везикова Н.Н. Проблема остеопороза у больных ревматоидным артритом. Совр. ревматол. 2009; 4: 40-4.</p><p>Торопцова Н.В. Остеопороз: взгляд на проблему диагностики и лечения. Совр. ревматол. 2009; 3: 69.</p><p>Geza B. Vizsgalatok a genericus alen- dronat natriummal, a Sedronnal. Praxis 2008; 17: 731-41.</p></div><br />
Review
For citations:
Raskina TA, Letaeva MV. GENDER PECULIARITIES OF THE OSTEOPENIC SYNDROME IN THE DEPENDENCE ON THE RHEUMATOID INFLAMMATION ACTIVITY. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2010;4(3):28-33. (In Russ.) https://doi.org/10.14412/1996-7012-2010-616
Views:
1382
Email this article 